Results for tag: "Intestinal Obstruction Drug"

The Intestinal Obstruction Drug market is a subset of the Gastrointestinal Drugs market, which includes drugs used to treat diseases and disorders of the digestive system. Intestinal Obstruction Drugs are used to treat conditions such as adhesions, hernias, and volvulus, which can cause blockages in the intestines. These drugs can be administered orally, intravenously, or rectally, depending on the severity of the obstruction. Commonly used Intestinal Obstruction Drugs include opioids, antispasmodics, and anticholinergics. These drugs work by reducing inflammation, relaxing the muscles of the intestines, and relieving pain. Some companies in the Intestinal Obstruction Drug market include AbbVie, AstraZeneca, GlaxoSmithKline, Merck, Pfizer, and Sanofi. Show Less Read more